Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Growblox Sciences Inc (OP: GBLX )

0.0775 USD UNCHANGED
Streaming Delayed Price Updated: 3:58 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Growblox Sciences Inc

< Previous 1 2 3 4 5 6 Next >
Profits From Legal Cannabis Sales Projected to Rise
FinancialBuzz.com News Commentary 
From PR Newswire
Legal Cannabis Market Continues to Mature
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Exceeds Its Gross Revenue Projections for October, Doubles the Industry Average Yield Per Active Flower Light
GB Sciences, Inc. (OTCQB: GBLX) announces that it has exceeded the October gross revenue projection of $500K from the sale of premium flower by 2%. Gross sales projections for the month of November are... 
From PR Newswire
GB Sciences is Happy
Mr. Kevin Kuethe has been appointed COO of GB Sciences. The company is happy, the plants are happy, the customers are happy, and the shareholders should definitely be happy. 
From PR Newswire
GB Sciences Inducts Scientific Advisory Board: Dr. Andrea Small-Howard of GB Sciences, Dr. Helen Turner of Chaminade University, Dr. Norbert Kaminsky of Michigan State University, and Dr. Carlos Ríos-
The Scientific Advisory Board will oversee the development of GB Sciences' Cannabis-Based Therapies and Clinical Trials 
From PR Newswire
GB Sciences, Inc. Partners With Cura Cannabis Solutions And Enters The Lucrative Cannabis Oil Market In Nevada
This production agreement guarantees GB Sciences a set royalty on every gram produced and sold. It is projected to add significant net profits to the bottom lines of both partners in 2018 
From PR Newswire
GB SCIENCES, INC. PARTNERS WITH CURA CANNABIS SOLUTIONS AND ENTERS THE LUCRATIVE CANNABIS OIL MARKET IN NEVADA
This production agreement guarantees GB Sciences a set royalty on every gram produced and sold. It is projected to add significant net profits to the bottom lines of both partners in 2018 
From GlobeNewswire News Releases
GB SCIENCES, INC. PARTNERS WITH CURA CANNABIS SOLUTIONS AND ENTERS THE LUCRATIVE CANNABIS OIL MARKET IN NEVADA
This production agreement guarantees GB Sciences a set royalty on every gram produced and sold. It is projected to add significant net profits to the bottom lines of both partners in 2018 
From GlobeNewswire News Releases
The Relationship Between Legal Cannabis and the Plant Factory Grows Lights Market
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Receives The Prestigious 'Spirit Of The Law' Award
Clear Recognition of GB's Contributions and Commitment to Quality Patient Care 
From PR Newswire
GB Sciences Increased Sales 400% Since First Harvest
GB Sciences, Inc. (OTCQB: GBLX) projects sales of $500,000 in October and continued sales of at least $500,000 per month over the next three months. GB Sciences recorded unaudited sales of... 
From PR Newswire
GB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for Neuropathic Pain
GB Sciences, Inc. (OTCQB: GBLX) has obtained the exclusive worldwide license to intellectual property covering a time-released cannabinoid formulation from the Universidad de Seville (“USE”), the... 
From GlobeNewswire News Releases
GB Sciences Obtains Exclusive Worldwide License on a Time-Released Cannabinoid Formulation for Neuropathic Pain
GB Sciences, Inc. (OTCQB: GBLX) has obtained the exclusive worldwide license to intellectual property covering a time-released cannabinoid formulation from the Universidad de Seville ("USE"), the... 
From PR Newswire
Nanotechnology Research Collaboration with Universidad de Sevilla to Create Time-Released Formulation for GB Sciences' THC-Free Chronic Pain Therapy
GB Sciences, Inc. (OTCQB: GBLX) has entered into a Contract Research Agreement with the Universidad de Sevilla ("USE") to develop a time-released version of GB Sciences' proprietary, THC-free,... 
From PR Newswire
Marijuana and Cannabis Business Becoming One of the Market's Fastest Grow Industries
MarketNewsUpdates.com News Commentary 
From PR Newswire
Innovative Partnership Forged Between LSU AgCenter And GB Sciences To Advance The Understanding Of The Cannabis Plant
GB Sciences, Inc. (OTCQB: GBLX) announces that Louisiana State University (LSU) AgCenter has signed their agreement with GB Sciences Louisiana, LLC, a wholly-owned subsidiary of GB Sciences, Inc., for... 
From PR Newswire
Cannabis Legalization Gains Popularity
FinancialBuzz.com News Commentary 
From PR Newswire
Sales of Medical Cannabis Products Are Expected to Grow
FinancialBuzz.com News Commentary 
From PR Newswire
Uptick Newswire Presents Its First Category Nominees for the 2017 Uppie Awards Show
From ReleaseWire - Latest Press Releases
GB Sciences Initiates Cannabis-based Therapy Clinical Trials Consulting Services Agreement with Worldwide Clinical Trials, Inc.
GB Sciences, Inc. (OTCQB: GBLX) has signed a Consulting Services Agreement with Worldwide Clinical Trials, Inc. to evaluate the company's intellectual property portfolio and to assist with pre-IND... 
From PR Newswire
GB Sciences Inc. Adds Provisional Nevada Recreational Cannabis License for Branded Recreational Products
GB Sciences Will Bring Medical-Grade Cannabis to the Recreational Use Market by Introducing Cultivation Labs™ Branded Products 
From PR Newswire
GB Sciences Sells First Cannabis Harvest and Officially Enters Revenue Mode
The first cannabis crop harvest yielded 133 pounds of product from 45 lights. 63 pounds were sold as premium flower, with 66.5 pounds held back for conversion to medical grade cannabis oil. 
From PR Newswire
Legal Cannabis Market Projected to Grow Due to Medical Applications
FinancialBuzz.com News Commentary 
From PR Newswire
GB Sciences Wins Louisiana State University (LSU) Bid to Act as LSU Agricultural Center's Exclusive Operator of Medical Cannabis Production Facility
The LSU Agricultural Center has one of the only two licenses granted by the State of Louisiana to cultivate, distribute and sell medical cannabis. In addition, GB Sciences will have first rights to... 
From PR Newswire
Legal Marijuana and CBD-based Products Increasing Demand Continues to Drive Revenue Growth
MarketNewsUpdates.com News Commentary 
From PR Newswire
GB Sciences Announced As LSU Bid Winner
GB Sciences, Inc. (OTCQB: GBLX) 
From PR Newswire
GB Sciences Builds Broad Cannabis Patent Portfolio -- CFN Media
From Marketwired News Releases
Cannabiol Generating Enormous Revenues Potential as CBD Products Continue to Gain Consumer Popularity
MarketNewsUpdates.com News Commentary 
From PR Newswire
GB Sciences Files Patent Application for Chronic Pain and Heart Therapies
GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce the filing of its latest patent application by its wholly-owned subsidiary, Growblox Life Sciences, LLC for the treatment of chronic pain and... 
From PR Newswire
GB Sciences, Inc. Announces The Appointment Of Mr. Leslie Bocskor As Vice Chairman
GB Sciences, Inc. (OTCQB:GBLX) is pleased to announce the appointment of Mr. Leslie Bocskor as Vice Chairman, effective April 28, 2017. John Poss remains Chairman of the Board and CEO. 
From PR Newswire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.